Results 221 to 230 of about 1,106,155 (263)
Some of the next articles are maybe not open access.
Immune Thrombocytopenia in Lymphoproliferative Disorders
Hematology/Oncology Clinics of North America, 2009Lymphoproliferative disorders are recognized as a common cause of secondary immune thrombocytopenia (ITP). The mechanisms involved in the pathogenesis of ITP associated with lymphoproliferative disorders are heterogeneous and often linked to the presence and activity of the malignant clone.
Visco, Carlo, Rodeghiero, Francesco
openaire +2 more sources
Angiogenesis in Lymphoproliferative Disorders
Acta Haematologica, 2001In this review, the cellular and molecular mechanisms underlying angiogenesis in lymphoproliferative disorders are summarized, alongside with possible therapeutic applications. Although most of the initial studies in angiogenesis were done on solid tumors, recent data demonstrate the importance of angiogenesis in hematological malignancies including ...
openaire +2 more sources
Gastrointestinal lymphoproliferative disorders
Histopathology, 2006Malignant lymphomas can be first detected in some patients in endoscopic biopsies of the gastrointestinal (GI) tract. However, their recognition and accurate classification often pose problems for the pathologist for several reasons. First, the small sampling size limits pattern recognition and the number of ancillary studies which can be performed ...
openaire +2 more sources
Benign lymphoproliferative disorders
Seminars in Oncology Nursing, 1996To provide a review of three benign lymphoproliferative disorders commonly encountered in nursing practice: (1) infectious mononucleosis, (2) cat scratch disease, and (3) sarcoidosis.Research studies, review articles, and book chapters pertaining to benign lymphoproliferative disorders.Benign lymphoproliferative disorders may be associated with ...
openaire +2 more sources
Chronic lymphoproliferative disorders
Current Opinion in Oncology, 1997Chronic lymphoproliferative disorders are a heterogeneous group of diseases with a highly variable clinical course. In the past few years, important progress has been made in the classification, biology, and therapy of some of these disorders of which B-cell chronic lymphocytic leukemia is not only the most frequent but also the model for their study ...
openaire +2 more sources
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
Cancers, 2022Joshua Dower +2 more
exaly
Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient
Endocrine, Metabolic and Immune Disorders - Drug Targets, 2022Ana Krolo, Kaan Boztuğ, Elham Rayzan
exaly